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Recent data with CD8+T cells show that the initial phase ofT cell receptor (TCR) binding to
MHC–peptide (MHCp) is quickly followed by a second, stronger, binding phase represent-
ing the binding of CD8 to the MHCp. This second phase requires signaling by a Src-family
kinase such as Lck. These data point out two aspects of the initial stage of TCR signaling
that have not yet been clearly resolved. Firstly, how and by which Src-family kinase, is
the initial phosphorylation of CD3ζ accomplished, given that the Lck associated with the
co-receptors (CD4 or CD8) is not yet available. Secondly, what is the mechanism by which
the co-receptor is brought close to the boundTCR before the co-receptor binds to MHCp?
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INTRODUCTION
Recognition of antigen as MHC–peptide (MHCp) complexes by
the T cell receptor (TCR) is the ﬁrst stage of T cell activation, and
therefore critical to all adaptive immune responses to pathogens
and cancers, as well as to autoimmunity. The binding of TCR to
MHCp initiates a protein kinase signaling cascade that branches
out as it proceeds, to encompass various signaling pathways lead-
ing to changes in cell shape, adhesion, and motility, as well as to
changes in gene transcription.
There are several models for how TCR interaction with MHCp
can lead to initial triggering of the signaling cascade. These have
been comprehensively reviewed (Germain, 2001; Krogsgaard and
Davis, 2005; van der Merwe and Dushek, 2011), so will only be
brieﬂy mentioned here. They fall into several groups, aggregation,
conformation/architectural changes, and separation models. Evi-
dence from studies of T cells activated byAPCor by solubleMHCp
indicate that some kind of crosslinking or aggregation of two or
more TCRs is required (Boniface et al., 1998; Cochran et al., 2000;
Cebecauer et al., 2005). TCRs are grouped into microclusters dur-
ing antigen recognition (Yokosuka et al., 2005; Varma et al., 2006),
and there is also some evidence for pre-formed aggregations of
TCRs existing on the cell surface (Schamel et al., 2005; Lillemeier
et al., 2006, 2010; Kumar et al., 2011). Clustering of the TCRs by
antigen recognition aided by weak interactions with endogenous
MHCp and the recruitment of co-receptor-bound Lck to the site
of recognition would then start the signaling cascade (Krogsgaard
and Davis, 2005; Gascoigne, 2008). Conformational changes have
been proposed as a mechanism for signal transduction, but apart
from movement in the CDRs during binding to MHCp, confor-
mation change upon antigen binding has only been found as a
movement of part of the Cα domain, in a region predicted to
interact with CD3ε (Kjer-Nielsen et al., 2003; Beddoe et al., 2009).
Conformation changes in intracellular domains of CD3 seem to
be involved in allowing signaling adaptor proteins to interact with
CD3 (Gil et al., 2002) or for accessibility for immunoreceptor
tyrosine-based activation motif (ITAM) phosphorylation (Xu
et al., 2008). A conformational/architectural model has received
strong recent support whereby mechanical pulling by the TCR–
MHCp interaction puts torque on the CD3 subunits, leading to
signal transduction (Kim et al., 2009; Li et al., 2010). In the kinetic
separation model, the interaction between short molecules like
TCR and MHC at the immunological synapse requires that larger
molecules such as cell adhesion molecules and the phosphatase
CD45 are pushed out to the periphery. Removal of negative reg-
ulators of signaling could thus aid phosphorylation steps at the
center of the synapse (Davis and van der Merwe, 2006). These dif-
ferent classes of model are not necessarily mutually exclusive, and
indeed elements of each class seem to operate in T cell activation
(van der Merwe and Dushek, 2011).
The very ﬁrst stage of the TCR signaling cascade after TCR–
MHCp binding is the phosphorylation of the CD3ζ subunits of
the TCR. The TCR–CD3 complex consists of the TCRα and β
chains that recognize MHCp, and the CD3γε, δε, and ζζ dimers
that form the signal transduction modules of the TCR. All of
these subunits are cell surface transmembrane proteins and all
have at least one ITAM in their cytoplasmic domain. CD3γ, δ, and
ε each have one ITAM, while CD3ζ has three. At the start of the
signaling cascade, the CD3ζ ITAMs are phosphorylated, and are
then bound by another kinase called ZAP70. Each ITAM has dual
tyrosines so that when they are both phosphorylated, they form
a high afﬁnity binding site for the dual SH2 domains of ZAP70.
After ZAP70 binds to CD3, the co-receptors CD4 or CD8, which
are associated with the Src-family kinase Lck, become associated
with the TCR–CD3 complex and bind to MHC. This stabilizes the
TCR–MHCp interaction, and Lck continues the phosphorylation
of CD3 elements, ZAP70 and the many other downstream targets.
A recent biophysical study on TCR and CD8 binding to MHCp
demonstrated that the initial binding of TCR to MHCp induces,
in a Src-family kinase-dependent manner, the binding of CD8 to
the MHCp (Jiang et al., 2011). This illustrates two related and
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important problems in understanding T cell activation that have
never been fully resolved. Firstly, how is the ﬁrst CD3 phospho-
rylation step accomplished, and by which Src-family kinase(s)?
Secondly, if the co-receptor is brought to the activated TCR before
the co-receptor binds to MHC,but after TCR signaling has started,
how is this initial recruitment to the TCR accomplished?
Rather little is known about these earliest steps in T cell acti-
vation. Lck is a major target for drug discovery, as small mole-
cule inhibitors could be used as immunosuppressives, for exam-
ple in autoimmunity, rheumatoid arthritis, or asthma. Current
inhibitors are not very selective, also inhibiting other Src-family
kinases or other kinases (Martin and Machacek, 2010). It is there-
fore important to understand exactly how Src-family kinases work
in T cell activation.
TCR BINDING TO MHCp AUGMENTS CD8 BINDING TO MHC
It was shown in the early 1990s that stimulation of the TCR
enhances the binding of CD8 to MHC class I (MHCI), and that
this increase in binding requires tyrosine kinase activity (O’Rourke
et al., 1990; O’Rourke and Mescher, 1992). Recently, a cell-based
adhesion frequency assay was developed that enables investiga-
tion of molecular interactions at the cell surface with very fast
time resolution (Huang et al., 2007, 2010; Jiang et al., 2011). This
method is based on touching a T cell to a red blood cell coated
with appropriate MHCp ligands, then retracting it, and measur-
ing whether or not the red blood cell membrane is distorted. This
process is repeated multiple times with the interaction allowed
to continue for certain ﬁxed periods. For each of these inter-
action times, an adhesion frequency is calculated. This method
showed clearly that TCR and CD8 interactions with MHCp are
biphasic (Jiang et al., 2011). The ﬁrst phase – the initial TCR
interaction with ligand – starts within the ﬁrst 0.25 s after the
cell surfaces make contact (Figure 1). After about 1 s of contact,
a second, stronger, binding phase occurs. Initiation of the second
phase requires a Src-family tyrosine kinase, as it does not occur
when the inhibitor PP2 is present. The ﬁrst phase is co-receptor-
independent but the second phase is co-receptor dependent, as the
secondphase is blockedby anti-CD8antibodies anddoesnot occur
when the CD8 binding site of MHCI is non-functional. Thus, the
ﬁrst phase is the TCR interaction. This is followed by a second
phase of TCR-induced CD8 binding (Jiang et al., 2011). There is
also a CD8–MHCI interaction that occurs without stimulation of
the TCR. This is weaker than the TCR–MHCp interaction, but
like that, it has single-stage kinetics and reaches a plateau at about
1 s (Huang et al., 2007). This CD8–MHCI interaction is sufﬁ-
cient to concentrate CD8 at the interface between a T cell and an
antigen-presenting cell (Yachi et al., 2005, 2006; Gascoigne et al.,
2010).
This two-step activation (Jiang et al., 2011) does not ﬁt with
the classical model of TCR triggering, where the co-receptor
binding to MHCp is required for Lck to phosphorylate CD3
ITAMs. It is compatible with aggregation models such as the
pseudodimer or co-receptor pre-concentration models, where the
co-receptor’s extracellular domains bind to non-cognate MHCp
but the co-receptor-bound Lck interacts with the antigen bind-
ing TCR/CD3 within the cell (Krogsgaard et al., 2007; Gascoigne,
2008). It is also consistent with those models requiring a con-
formation/architectural change due to antigen binding, providing
that the initial phosphorylation of CD3 recruits the co-receptor
through the interaction of Lck with phospho-ITAMs.
INITIAL PHOSPHORYLATION OF TCR–CD3 IN T CELL
ACTIVATION
Several lines of evidence indicate that the initial phosphorylation
of CD3ζ ITAMs and ZAP70 is caused by a Src-family kinase (Lck
and/or Fyn) that is not bound to CD4 or CD8, yet the mechanism
of this process that initiates the TCR signaling cascade is poorly
deﬁned (Acuto et al., 2008). It is clear that co-receptors are not
absolutely required for TCR signaling as some T cells are inde-
pendent of co-receptor, and the requirement for CD8 has been
shown to be inversely related to the afﬁnity of the TCR. TCRs
with afﬁnity above a certain threshold do not need co-receptor
(Cho et al., 2001; Holler and Kranz, 2003). Another piece of evi-
dence is that thymocyte development requires the presence of
Lck, but co-receptors are not absolutely required for thymocyte
development (Schilham et al., 1993; Van Laethem et al., 2007).
In addition, the fact that CD8 does not bind MHC to stabilize
TCR binding until after signaling has started argues this point
strongly (Jiang et al., 2011). Lck can be co-precipitated with
TCR/CD3 in mild detergents (Schraven et al., 1993; Stefanova
et al., 2003), but although Lck can be co-capped with co-receptor
(after crosslinking by suitable antibody), it does not co-cap with
TCR (Ehrlich et al., 2002). Fyn can also be co-precipitated with
the TCR in mild detergents (Samelson et al., 1990; Timson Gauen
FIGURE 1 | A model for initiation ofTCR–CD3 phosphorylation, and the
recruitment of the co-receptor. (A) Before TCR interaction with MHCp. Lck
and/or Fyn are associated with the plasma membrane, and Lck also exists
associated with CD8. UponTCR binding to MHCp (B) the Fyn and/or non-CD8
bound Lck becomes associated with theTCR–CD3 complex, and
phosphorylates CD3ζ ITAMs and then ZAP70 which binds to the
phosphorylated CD3ζ ITAMs. (C)The SH2 domain of CD8 bound Lck then
interacts with the phospho-ZAP70, pulling CD8 into proximity with the
MHCp-interacting TCR. (D)The extracellular immunoglobulin domains then
bind to the MHCp, stabilizing theTCR–MHCp interaction.
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et al., 1992; Schraven et al., 1993; Fusaki et al., 1996). Thus there
is evidence that both Lck and Fyn can associate in some way
with TCR, but at very low stoichiometry. Also, because these
experiments used detergents that do not disrupt lipid rafts, it is
possible that the interactions were artifacts due to the detergent
lysis method causing interactions between normally separate lipid
domains.
Fyn or Lck individually can both perform the constitutive
phosphorylation of TCR/CD3 required for maintenance of cell
viability in vivo, but Lck-deﬁcient cells have stronger defects in
most aspects of signaling than Fyn-deﬁcient cells. The signaling
differences between T cells from Fyn and Lck knockout mice are
summarized in Table 1. Because of the block in positive selection
in Lck−/−mice, data on Lck-deﬁciency in mature T cells have come
Table 1 | Defects inTCR signaling and development in the absence of Lck and/or Fyn.
Activity/TCR-dependent
signaling pathway
Defect in Lck KO?* Defect in Fyn KO? Defect in double KO?* Notes
Development through
pre-TCR checkpoint
Strong defect, but
incomplete
Little or no defect Complete block at DN3 Fyn activity in absence of Lck enables some
development to proceed but double KO
completely abrogates development to SP
(Appleby et al., 1992; Molina et al., 1992;
Stein et al., 1992; Groves et al., 1996; van
Oers et al., 1996a)
Development through
positive selection
checkpoint
Strong defect Little or no defect Development blocked
before this stage (at
DN3)
Fyn activity in absence of Lck is minor
(Appleby et al., 1992; Stein et al., 1992)
CD3ζ phosphorylation
(constitutive)
Minor defect Minor defect strong Either Lck (at normal quantity) or Fyn is
sufﬁcient for survival of T cells, but low
Lck expression not sufﬁcient (Seddon and
Zamoyska, 2002)
TCR-stimulated CD3ζ,
ZAP70, LAT
phosphorylation
Major reduction Minor defect Stronger defect than
Lck KO
Fyn is not very important (Van Oers et al.,
1996b), but it has a minor role (Lovatt et al.,
2006; Filby et al., 2007)
PLCγ1 phosphorylation Major defect Little or no defect Major defect Fyn alone cannot transduce signals leading
to PLCγ1 activation (Appleby et al., 1992;
Stein et al., 1992; Lovatt et al., 2006)
DAG production and
RasGRP translocation to
plasma membrane
Major defect Little or no defect Major defect Lovatt et al. (2006)
Ca2+ ﬂux Major defect Minor defect Major defect Appleby et al. (1992), Lovatt et al. (2006),
Stein et al. (1992)
Erk pathway activation Partial defect Partial defect Major defect Both Fyn and Lck are involved in Erk activa-
tion. Fyn alone activates Erk by a different
pathway than PLCγ1-RasGRP (Lovatt et al.,
2006; Filby et al., 2007)
PI3K activation Slight defect Slight defect Major defect Either Fyn and Lyk are sufﬁcient to activate
PI3K pathway (Salmond et al., 2009b)
Phosphorylation of
ribosomal protein S6
Slight defect Slight defect nd Both Lck and Fyn required for full phospho-
rylation of rpS6, downstream of Erk and
PI3K pathways (Salmond et al., 2009a)
Pyk2 phosphorylation Little or no defect Major defect nd Fyn is required for phosphorylation of the
focal adhesion kinase Pyk2 (Qian et al.,
1997)
Csk binding protein
(Cbp/PAG) phosphorylation
nd Major defect nd Fyn is required for activation of Cbp/PAG
(Yasuda et al., 2002)
Negative feedback onTCR
signaling
No defect KO allows stronger
signaling
Filby et al. (2007)
∗Data on mature T cells deﬁcient in Lck expression is from mouse with inducible Lck expression, which can be turned off after development (Legname et al., 2000;
Seddon et al., 2000). nd, Not determined.
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from a very elegant inducible transgenic system bred onto the Lck
KO background. This transgene is turned on to allow normal T
cell development, then off so that Lck expression is gradually lost.
Transgenic Lck expression inmature T cells is, however, only about
10–20% of the normal amount (Seddon et al., 2000; Lovatt et al.,
2006). For the most part, the defects in Fyn-deﬁcient T cells were
rather modest, but recent studies have shown that Fyn may in fact
be a negative regulator of TCR signaling. Stimulation with anti-
gen (or with crosslinking anti-CD3 plus anti-CD8) gave stronger
and faster responses in the absence of Fyn (Filby et al., 2007).
This is in contrast to earlier studies that showed that cells lacking
Fyn gave lower responses than normal to anti-CD3 stimulation (as
opposed to antigen or anti-TCRplus anti-co-receptor stimulation;
Reviewed in Palacios and Weiss, 2004; Salmond et al., 2009b).
Most interestingly, in Lck knockout mature T cells, Fyn directs
relatively strong Erk activation, but reduced LAT phosphoryla-
tion, while PLCγ1 phosphorylation and Ca2+ signaling do not
occur (Lovatt et al., 2006; Filby et al., 2007). Fyn may therefore
act through a different pathway than Lck to activate Erk. A direct
interaction of Grb2–SOS with CD3ζ has been suggested (Chau
and Madrenas, 1999; Methi et al., 2007), which could perhaps pro-
vide such a pathway. However, T cell activation is very strongly
dependent on the RasGRP pathway to activate Ras and then Erk,
and it is unclear if SOS has any crucial role (Dower et al., 2000;
Priatel et al., 2002). It may also be important to consider that these
studies in Lck or Fyn-deﬁcient cell lines or knockout mice have
not distinguished free Lck from that bound to the co-receptor.
Resting T cells and thymocytes contain substantial quantities of
both activated Lck and Fyn, and stimulation through TCR or co-
receptor does not increase the proportion of the activated kinases
(Nika et al., 2010). BothLck andFyn are targeted to the inner leaﬂet
of the plasma membrane in lipid rafts through palmitoylation
and myristoylation of their amino termini. This fatty acylation is
required for Fyn to interact with and phosphorylate CD3ζ ITAMs
(van’t Hof and Resh, 1999). Lipid-raft targeting by fatty acylation
is also the case for Lyn, a Src-family kinase that is important in
initiation of BCR signaling. A recent experiment showed that Lyn
interacts with the BCR after BCR crosslinking by binding to anti-
gen, when Ag-induced BCR microclusters interact with lipid rafts
(Sohn et al., 2008). A similar mechanism is likely to apply for the
initiation of TCR signaling by Lck and/or Fyn.
Yet another complexity comes from single-molecule studies
of the movement of cell membrane-associated molecules. Stim-
ulation by very small clusters of anti-CD3 antibodies on a solid
surface showed that a raft-targeted construct (the amino terminal
of Lck with the fatty acylation sites) or full-length Lck both con-
centrated quickly at the stimulation site and were retained there
(Ike et al., 2003). Diffusion was slower closer to the site of stim-
ulation, and faster away from these sites. Directed movement of
Lck was not seen, indicating that Lck was not brought to the sig-
naling region by actin, but concentration at the stimulation site
was blocked by drugs that either poisoned the cytoskeleton or dis-
persed lipid rafts. Clustering of the actin ﬁlaments at the site of
activation (Wulﬁng and Davis, 1998) would slow diffusion away
from the activation site, either because the actin mesh impedes
free diffusion of the membrane-bound protein, or because of
a “picket fence” of transmembrane proteins associated with the
cytoskeleton. These phenomena would lead to “corralling” of Lck
(and rafts) at the activation site (Ike et al., 2003). Others have
described a similar phenomenon of microdomains caused by pro-
teins rather than lipids,where it was noted that CD45was excluded
frommicrodomains that contained Lck (Douglass andVale, 2005).
This study also demonstrated that various T cell signaling proteins
were able to move quickly from one microdomain to another.
A protein such as annexin A6, which binds negatively charged
phospholipids, lipid rafts, and F-actin, could organize and bridge
different kinds of microdomains and/or rafts around signaling
receptors (Cornely et al., 2011).
HOW IS CD8 RECRUITED TO THE ACTIVATED TCR BEFORE
CD8 INTERACTS WITH MHC?
The data on biphasic TCR and CD8 interactions with MHCp show
that in a very quick sequence, TCR binds MHCp, causing Src-
family kinase activity, then CD8 binds to the MHC and stabilizes
the interaction between the three molecules (Jiang et al., 2011).
If CD8 does not bind to MHCp until the second stage, then how
is the co-receptor initially recruited to the TCR? It has generally
been assumed that this is accomplished by CD8 binding to MHC,
but this does not ﬁt with the new data. It has been suggested that
CD8 is brought into the signaling complex passively, through an
interaction of the Lck molecule attached to CD8 with one of the
phospho-tyrosines produced by the initial signal on CD3ζ, or to
phospho-ZAP70 (Jiang et al., 2011).
There is in fact some strong but rather old evidence supporting
such a mechanism. A study using a chimera between CD4 and Lck
demonstrated that the SH2 domain of Lck was involved in CD4
co-receptor activity: a mutation stopping the Lck SH2 from bind-
ing phosphotyrosine partially reduced co-receptor activity (Xu
and Littman, 1993). This suggested that a protein–protein interac-
tion mediated by Lck’s SH2 domain is important for co-receptor
function, and indeed it has since been shown that after TCR stim-
ulation, the Lck SH2 domain binds to phospho-ZAP70 bound to
phospho-CD3ζ, and that this interaction causes the co-receptor
to come into proximity with TCR (Thome et al., 1995, 1996). As
mentioned above, much of the Lck in resting T cells is activated
kinase, and this activity is not affected by TCR stimulation (Nika
et al., 2010), but kinase activity is not required for the co-receptor
function of CD4 (Collins and Burakoff, 1993; Xu and Littman,
1993). The CD4 co-receptor is bound to both active and inactive
Lck (Nika et al., 2010), indicating that there is no simple expla-
nation. The protein–protein interaction functions of Lck during
TCR activation deserve more detailed analysis.
CD8 exists as both anααhomodimer and as theαβheterodimer
that is the main co-receptor for T cell activation. Both forms are
equivalent in their ability to bind to classical MHCI, but CD8αα
binds much more strongly than CD8αβ to the non-classical MHCI
molecule H2-TL (Cheroutre and Lambolez, 2008). CD8αβ is a
much stronger co-receptor than CD8αα, probably because of pref-
erential localization of CD8αβ to lipid rafts where it is more
likely to interact with Lck. We tested the ability of the two forms
expressed on the same cell to be recruited to the site of antigen
recognition, and found that therewas very little difference between
them (Rybakin et al., 2011). If H2-TL was present on the antigen-
presenting cell, then the CD8αα form was preferentially recruited,
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leading us to the conclusion that the ability of the CD8 isoforms
to be recruited to the immunological synapse was not directly
related to their co-receptor ability, but simply to the strength of
their interaction with MHCI.
DIFFERENT PHASES IN THE TCR INTERACTION WITH
CO-RECEPTOR
In previous studies from this lab, we used Foerster resonance
energy transfer (FRET) microscopy in live cells to investigate the
interaction of both CD4 and CD8 with TCR, using CD3ζ–CFP
as FRET donor and CD4–YFP or CD8β–YFP as FRET acceptors
(Zal et al., 2002; Gascoigne and Zal, 2004; Yachi et al., 2005, 2006;
Gascoigne et al., 2009). We showed that the co-receptors inter-
act closely with the TCR only when TCR recognizes antigen, even
though both CD4 and CD8 can be recruited to the immunologi-
cal synapse without any requirement for antigen recognition. This
was most striking for CD8, which binds to non-antigenic MHCI
molecules and can be concentrated in the immunological synapse
in proportion to the number of MHCI proteins available (Yachi
et al., 2005; Gascoigne et al., 2010). We found that the strength
of the FRET signal between the TCR–CD3 complex (CD3ζ–
CFP→CD8β–YFP FRET) corresponded closely to strength of T
cell activation by particular peptides, and that differences in FRET
kinetics during recognition of different MHCp ligands correlated
closely to the ability of a particular ligand to induce positive or
negative selection in thymocytes (Yachi et al., 2006; Mallaun et al.,
2008). However, the kinetics of the close apposition of TCR and
CD8 were slower than expected from other measures of T cell acti-
vation, as they developed over several minutes, peaking at about
10min (Yachi et al., 2005, 2006). Early signaling events such as
LAT phosphorylation or calcium ﬂux occur within a few seconds,
although other events like cytoskeletal rearrangement for exam-
ple, are on a longer timescale of a few minutes (Huse et al., 2007).
In more recent higher-resolution experiments using a supported
lipid bilayer system, we have been able to image TCR–CD8 FRET
in small regions within the immunological synapse (J. Casas and
Nicholas R. J. Gascoigne, unpublished). These were too localized
to show a signal above the background when FRET signals were
averaged over the whole synapse, explaining why they were not
noticed before. This leads us to believe that the strong FRET sig-
nalsmeasured previously in synapses with antigen-presenting cells
that were on the timescale of minutes (Yachi et al., 2005, 2006),
represent the result of stabilization of TCR–MHCp binding by
the co-receptor – the second phase of interaction identiﬁed in the
cell–cell adhesion experiments (Jiang et al., 2011), rather than the
ﬁrst.
TheTCRα-chain connecting peptidemotif (α-CPM) is a highly
conserved membrane-proximal extracellular sequence motif in
the TCR α-chain. It is important for the ability of CD8 to associate
with TCR to enhance T cell responses (Naeher et al., 2002; Mal-
laun et al., 2008), and for T cell activation and positive selection
(Werlen et al., 2000). Mutation of the α-CPM reduced the stable
FRET response between TCR and CD8 (Mallaun et al., 2008).
The α-CPM is believed to work by interacting with membrane-
proximal regions of CD8β in a “co-receptor zipper” mechanism,
enabling Lck to completely phosphorylate theCD3 ITAMs (Palmer
and Naeher, 2009). CD8β is reported to interact primarily with
CD3δ (Doucey et al., 2003). The molecular basis of the interac-
tion between the α-CPM and CD8β is not clear, as it is unlikely
that CD8 could approach closely enough to the α-CPM to interact
with it directly, due to the presence of the CD3 subunits. However,
the transmembrane region of CD3εδ interacts with that of TCRα
(Call et al., 2002), and structural models place CD3εδ and TCRα
apposed to each other (Sun et al., 2004; Kuhns and Davis, 2007). It
has been suggested that movement within the TCR’s α-CPM could
apply torque to CD3εδ in the architectural/conformational change
model of TCR triggering described earlier (Kim et al., 2010). It
will be interesting to ﬁnd out how the α-CPM mutation affects
the two-stage TCR binding (Jiang et al., 2011). We predict that the
α-CPM will be involved in stabilization of the TCR–CD8 inter-
action after the initial TCR–MHCp binding, so that mutation of
the α-CPM will inhibit the second phase of TCR–MHCp binding
without affecting the ﬁrst phase.
FUTURE DIRECTIONS
The molecular details of the apparent adaptor function of Lck
need to be more clearly worked out, and indeed, a similar func-
tion may exist in other Src-family kinases. Lck and Fyn molecules
have overlapping but distinct roles at the beginning of TCR sig-
nal transduction, but the mechanisms for their initial interaction
with TCR to start the signaling cascade are still somewhat obscure.
Improvements in our ability to image TCR–CD8 FRET will allow
us to investigate separately the early and later phases of the TCR–
CD8 interactions. The early phase likely corresponds to the passive
recruitment of CD8 to TCR by the Lck interacting with phospho-
CD3ζ and/or phospho-ZAP70, whereas the later and stronger
phase of FRET is likely the result of stabilization of TCR–MHCp
bindingby the co-receptor. In this regard, it isworthnoting that the
two-stage binding model that shows co-receptor stabilization of
the TCR–MHCp interaction was performed in a MHCI-restricted
system. CD8 has a clear ability to stabilize the TCR–MHCp inter-
action, whereas CD4 does not. Indeed, modeling studies suggest
that the major role of co-receptors, particularly CD4, is sim-
ply to ferry Lck toward the site of TCR activation (Artyomov
et al., 2010). We are currently analyzing the different functions
of CD8 and Lck using mutational analyses and FRET microscopy.
The future application of super-resolution microscopy techniques
such as PALM and STORM (stochastic optical reconstruction
microscopy) will enable a nanometer-scale understanding of the
molecular interactions in the early phases of T cell activation.
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